Cancer Conference Update
Optimizing the Identification of HER2-Low Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:23:49
- Mas informaciones
Informações:
Sinopsis
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.
